To study the mutation profile of RYR in various types of cancers, we first investigated the distribution of mutations by mapping all RYR1, RYR2 and RYR3 mutations from 10,114 cancer patients recorded in the TCGA database (Fig. 1). This evidence concerns the gene RYR2 and cancer.